Polaris Market Research today announced findings from its latest report, projecting the global clinical nutrition for cancer care market to grow from USD 4.62 billion in 2023 to USD 7.11 billion by 2032, at a CAGR of 4.9% during the 2024–2032 forecast period. The report profiles ten leading companies across five market segmentation categories, including type, cancer type, age group, sales channel and region.

Analyst Commentary on Clinical Nutrition for Cancer Care Market Growth

“Malnutrition is a real risk for patients undergoing cancer treatment, and that clinical need is a central driver of market growth for oncology nutrition,” said a Polaris Market Research analyst. “The opportunity lies with companies that build clinical evidence, personalize formulations and reach patients through both hospital and online channels.”

Clinical Nutrition for Cancer Care Market Statistics at a Glance

• 2024 Market Size: USD 4.83 Billion
• 2032 Projected Size: USD 7.11 Billion
• CAGR (2024–2032): 4.9%
• Largest Region (2023): North America

Key Growth Drivers, Major Companies and Segments Covered

Growth Drivers: A growing cancer burden, rising malnutrition risk among oncology patients, and greater awareness of nutrition as a complementary therapy are the primary forces behind the market’s expansion, alongside growing demand for personalized oral nutrition. Cancer treatment often causes appetite loss and altered taste, raising the need for nutritional support. The American Cancer Society estimated around 1.9 million new cancer cases in the U.S. in 2022. Nutritional products can also help support immune function in patients receiving immuno-oncology drugs.

Major Companies Covered: Nestlé Health Science, Abbott Nutrition, Danone Nutricia, Baxter, Bayer AG, GlaxoSmithKline plc, Medtrition, Inc., Otsuka Holdings Co., Ltd., Pfizer Inc., Victus, Inc. The market is consolidated, with a few players holding a significant share through strong product portfolios and global presence.

Segments Covered: By Type (Oral Nutrition, Parenteral Nutrition, Enteral Feeding Formulas), By Cancer Type (Head & Neck, Stomach & Gastrointestinal, Blood, Breast, Lung), By Age Group (Adult, Paediatric), By Sales Channel (Offline, Online), By Region.

👉 Download a Free Sample of the Clinical Nutrition for Cancer Care Market Report →

https://www.polarismarketresearch.com/industry-analysis/clinical-nutrition-for-cancer-care-market 

Segment Insights and Market Restraints

Oral nutrition held the largest share by type in 2023, owing to ease of consumption and its value for patients with taste disturbances. By cancer type, lung cancer is projected to expand at a significant CAGR, as treatment side effects limit nutrient intake from regular food.

The main restraint is limited clinical evidence on recommended dietary requirements, along with the high price of premium supplements, regulatory hurdles and differences in dietary habits across regions.

Market Outlook: Evidence, Personalization and Access

The clinical nutrition for cancer care market is expected to benefit from greater emphasis on improving treatment outcomes and from the rising demand for personalized care. Growing research and development, aimed at generating evidence for the efficacy of nutritional products, is likely to strengthen physician confidence and broaden prescribing.

Adoption is also increasing in developing countries, where malnutrition risk among cancer patients is a growing concern. Companies launching new products for specific cancer types, and expanding across offline and online sales channels, are positioned to capture this demand. Better clinical data would help address the main restraint and support wider reimbursement and awareness over the forecast period.

Recent Developments in the Clinical Nutrition for Cancer Care Market

• January 2023: Nestlé India expanded its Health Science portfolio with ThickenUp Clear, a thickening solution for patients with swallowing difficulties linked to conditions such as head and neck cancer.
• July 2022: Nestlé Health Science introduced “Oral Impact Su Yi Su,” described as China’s first Food for Special Medical Purpose approved for patients with tumour conditions.

Regional Snapshot: North America Leads, Asia Pacific Fastest-Growing

North America led with the largest share in 2023, supported by a large cancer patient pool, nutritional assessment before treatment planning in the U.S., and active research and development by market players. Asia Pacific is projected to register the highest CAGR through 2032 on the back of rising cancer prevalence, malnourishment among patients, demand for early detection and growing awareness among doctors and patients.

Why It Matters for Buyers Evaluating the Clinical Nutrition for Cancer Care Market Forecast

For stakeholders researching the clinical nutrition for cancer care market forecast, the underlying report benchmarks market share, company positioning and segment-level projections to support sourcing, partnership and investment decisions through 2032. It also covers Porter’s Five Forces, PESTLE analysis and country-level data across five regions. Manufacturers, healthcare providers and investors can use these insights to compare product types and to identify high-growth cancer categories.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

animal-feed-market

graphite-market

experience-travel-services-market

functional-water-benefits-types-market

lithium-ion-battery-market

europe-chemical-distribution-market

adventure-tourism-market

profiling-top-10-firms-in-the-connected-cars-market-2025

ot-firewall-market